Related Experiment Video
Updated: Oct 31, 2025

Intestinal Epithelial Regeneration in Response to Ionizing Irradiation
Published on: July 27, 2022
Personalized Radiation Attenuating Materials for Gastrointestinal Mucosal Protection
James D Byrne1,2,3,4,5, Cameron C Young1, Jacqueline N Chu3,4,6
1Division of Gastroenterology Brigham and Women's Hospital Harvard Medical School 75 Francis St. Boston MA 02115 USA.
Personalized 3D-printed radioprotective devices significantly reduce gastrointestinal (GI) radiation injury in cancer patients. These devices offer a cost-effective method to protect sensitive tissues during radiation therapy.
Area of Science:
- Oncology
- Biomedical Engineering
- Radiology
Background:
- Therapeutic radiation for cancer frequently causes adjacent gastrointestinal (GI) tract mucosa injury.
- Protecting critical GI structures like the rectum and oral mucosa from radiation damage is crucial for patient outcomes.
Purpose of the Study:
- To develop and evaluate personalized 3D-printed radioprotective devices for reducing GI radiation toxicity.
- To assess the efficacy and cost-effectiveness of these devices in preclinical and clinical models.
Main Methods:
- Generating patient-specific 3D-printed radioprotective devices from CT scans using high-Z materials.
- Evaluating device efficacy in a rat radiation proctitis model and confirming optimal placement in a swine model.
- Performing dosimetric modeling in oral cavity and prostate cancer patients to quantify radiation dose reduction.
Main Results:
- A significant reduction in crypt injury was observed in the rat model (p < 0.0087).
- Dosimetric modeling showed a 30% radiation dose reduction to buccal mucosa and 15.2% to the rectum.
- The rectal radioprotectant device was found to be more cost-effective than a hydrogel rectal spacer.
Conclusions:
- Personalized radioprotective devices show promise in mitigating GI tissue injury during therapeutic radiation.
- These devices represent a novel approach to improve patient quality of life during cancer treatment.
- Further clinical implementation of these devices could enhance radiation therapy safety and efficacy.
More Related Videos
06:04Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
Published on: February 9, 2016
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors